# Spec 072 Exact-Range Review

## Binding

- Canonical base: `e2031bdef918980cc184aed811f381e41f5dfb8b`
- Reviewed head: `0843e39b9efaa463c1c6fdd404d3ec779223352b`
- Reviewed tree: `8a6ff1832e640ba6f567aea9974639c3969f07b4`
- Range: `29 files changed, 532 insertions, 79 deletions`
- Review tool: OpenCodeReview `v1.12.3`
- Delegate preview: `8 reviewable / 29 total`; merge base matched the canonical base exactly.

## Tooling honesty

`ocr review` was attempted for the exact range but no LLM endpoint was configured. The command failed before review with `no valid LLM endpoint configured`. No AI-review claim is made. OCR delegate rules were loaded for the eight Rust files, and the full range was manually reviewed, including Slint, planning, specification, and evidence files excluded by the tool.

## Manual coverage

- Rust contract/Doctor changes and backward-compatible historical MESC interoperability decoding.
- Spec 072 regressions, historical Spec 064/068 progression regressions, and Desktop utility-surface changes.
- Slint comparative-evidence copy and native route/product truth.
- BUILD_QUEUE, completion authority, Definition of Done, external gates, implementation authority, Start Here, and MESC project-separation governance.
- Spec 071 canonical closure evidence and the complete Spec 072 package/evidence/action packets.
- Release residual exactness, qualification honesty, scope boundaries, and repository-owned-vs-external authority.

## Findings resolved

1. Rebuilt-product qualification found stale comparative-superiority copy (`what OpenMed still does better`, `See where OpenMed is ahead`). It was replaced with pinned-evidence/claim-state wording and regressed against unsupported superiority verdicts.
2. The historical Spec 068 progression regression still required Spec 071. It was advanced to Spec 072 and now rejects premature Spec 073 progression.
3. Founder clarification established MESC as a separate project/repository, not a MedScale optional integration. Living governance, Doctor truth, Desktop integrations, release accounting, and Spec 072 regressions were corrected; historical Specs 012/036 remain provenance/backward compatibility only.
4. Spec 064 still required the stale `Optional / deferred` MESC product copy. The regression was corrected to require MESC absence from the current MedScale integration surface.
5. `PROJECT_COMPLETION_STATUS.md` simultaneously claimed no repository-owned Desktop/CLI unit remained while Spec 072 was `IN_PROGRESS`. The contradictory stale closure sentence was removed.
6. `REPOSITORY_IMPLEMENTATION_CLOSURE.md` still presented the Spec 067 closure as current authority after the founder reopened Specs 068-072. It is now explicitly a historical superseded baseline until Spec 072 closes and final closure is re-established.

## Convergence checks

- `git diff --check e2031bdef918980cc184aed811f381e41f5dfb8b...0843e39b9efaa463c1c6fdd404d3ec779223352b` — PASS.
- No current MedScale planning/product surface contains `MESC_RELEASE_BLOCKING`, a MESC release-gate table row, or `Optional / deferred` product copy. The only searched occurrence of `Optional / deferred` is historical finding prose in local qualification evidence.
- Current Doctor state is `SEPARATE_PROJECT / OUT_OF_SCOPE / gate=NONE`; MESC is excluded from MedScale execution, completion, release, and residual calculations.
- No current Desktop source/Slint assigns `PROVEN ADVANTAGE`, `OPENMED AHEAD`, `PARITY`, or `SURPASS`, and the stale superiority phrases are absent.
- Release Doctor residual set remains exactly five external MedScale evidence classes; no repository-owned release residual was invented or silently closed.
- Spec 072 remains the single promoted repository-owned unit until exact-head CI, protected merge, post-main verification, and canonical closure finish.

## Verdict

`NO_MATERIAL_FINDINGS_REMAIN`

This verdict is review convergence only. It does not authorize a release-ready claim and does not replace exact-head required CI, protected merge, post-main verification, or final canonical closure.
